Private company
Biolex
Logo: Biolex, Public domain, via Wikimedia Commons3
Former American biotechnology firm
Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors. It filed for Chapter 7 bankruptcy on July 5, 2012. The company focused on expression of difficult-to-synthesize recombinant proteins in its LEX platform, which used Lemna, a duckweed.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
See how the biggest companies compare on our leaderboards
Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors. It filed for Chapter 7 bankruptcy on July 5, 2012.2
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataBiolex on Wikidata
- 2WikipediaBiolex on Wikipedia
- 3Wikimedia CommonsBiolex logo by Biolex, Public domain